Gefitinib (250 mg daily) was initiated in October 2004, and the patient experienced significant symptom improvement within 3 weeks. She started gaining weight, the pain in her leg improved ...

Tyrosine kinase inhibitors, such as gefitinib (Iressa ™, ZD1839), block the EGFR. As a result, there is inhibition of cellular proliferation, promotion of apoptosis, and inhibition of anti ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

Mok and colleagues hypothesized that first-line therapy with the EGFR inhibitor gefitinib would be at least as efficacious as carboplatin–paclitaxel chemotherapy in former smokers and light ...

Gefitinib and erlotinib are commonly used as salvage treatment of unselected patients with recurrent NSCLC after first-line chemotherapy. This practice is primarily based on the results from the ...